Skip to content

Released Oct 30, 2026, before the open

10-Q filed Oct 30, 2026, 30 days after period end · 0000021665-26-000048

Q3 2026 · 10-Q
Revenue$5.37B+4.6% vs Q3 2025+0.1% vs Q2 2026
Net Income$751.00M+2.2% vs Q3 2025+8.4% vs Q2 2026
EPS Diluted$0.94+3.3% vs Q3 2025+9.3% vs Q2 2026
Gross Profit$3,233,000,000+6.0%
Operating Income$1,088,000,000+2.7%
Operating Cash Flowderived$1,171,000,000−7.1%
Free Cash Flowderived$1,037,000,000−6.2%
Margins · derived
Gross margin60.2%+0.8 pt vs Q3 2025
Operating margin20.3%−0.4 pt vs Q3 2025
Net margin14.0%−0.3 pt vs Q3 2025

What the release said

The Company narrowed its sales guidance and raised its gross profit margin and Base Business earnings per share guidance for full year 2026

The Company narrowed its full year 2026 sales guidance and raised its gross profit margin and Base Business earnings per share guidance, now expecting 5% to 7% Base Business EPS growth.12

Net cash provided by operations was $2,913 million for the first nine months of 2026.3

Net sales growth, third quarter 2026
4.6%4
Organic sales growth, third quarter 2026
3.6%4
GAAP diluted EPS, third quarter 2026
$0.945
Base Business EPS, third quarter 2026
$0.975
Net cash provided by operations, nine months 2026
$2,913 million For the first nine months of 20263
Full year 2026 net sales guidance
4% to 5% Now expected to be up 4% to 5%, versus 2% to 6% previously6
Thaler Agent · checked against the filing
Open the reading ›
The release

Same quarter

MetricQ3 2026Q3 2025Q3 2024Q3 2023
Revenue$5.37B$5.13B$5.03B$4.92B
Net Income$751.00M$735.00M$737.00M$708.00M
EPS Diluted$0.94$0.91$0.90$0.86

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Colgate Palmolive Co · CIK 21665 · Engraved from SEC EDGAR